Tiny Gems

Tuesday Sep 26, 2023 - 10:27 am

InvestorNewsBreaks – GEMXX Corp. (GEMZ) Enters Binding LOI to Acquire 50% Interest in Proven Yukon Gold Project

GEMXX (OTC: GEMZ), an enterprise specializing in gold, gemstone and jewelry production, today announced its entry into a binding letter of intent (“LOI”) to acquire an initial 50% stake in The Yukon Gold Project (“the property”), pending conclusion of due diligence and verification of the considerable exploration work already completed on the property and the assessments quantifying the proven and potential gold resources. According to…

Tuesday Sep 26, 2023 - 10:04 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Technology Services to Expand Deployment Across PENN Entertainment Portfolio

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced its entry into an agreement with PENN Entertainment, Inc. Under the agreement, Knightscope will offer its technologies to PENN Entertainment’s 43 nationwide gaming and racing properties. Knightscope recently deployed its first K5 ASR at Penn Entertainment’s M Resort Spa Casino in Nevada, followed with subsequent deployments at…

Tuesday Sep 26, 2023 - 9:33 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Commercial Class 3 EV EPA Certification

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has reached a key milestone. The company announced that it has received full approval from the Environmental Protection Agency (“EPA”) with certification for class 3 EV commercial vehicles; the company received the notification on Sept. 22, 2023. According to the announcement, the company has also completed all testing requirements for its class 3 EV Cab…

Monday Sep 25, 2023 - 9:16 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 Security Robot Deployed in NYPD Pilot Program

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced that the city of New York and the New York Police Department (“NYPD”) launched the Knightscope K5 security robot service. The move was announced at a press conference with the support of the Metropolitan Transportation Authority (“MTA”). The first two weeks will be spent on training, configuration…

Friday Sep 22, 2023 - 1:59 pm

InvestorNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Anticipating Growing Demand for UPNEEQ(R)

RVL Pharmaceuticals (NASDAQ: RVLP) is a a specialty pharmaceutical company whose near-term focus is to continue the rollout of UPNEEQ(R) into the medical aesthetics market through its dedicated sales force. “UPNEEQ(R) is the first non-surgical treatment option approved by the U.S. Food and Drug Administration (‘FDA’) for acquired blepharoptosis… UPNEEQ(R), the first and only FDA-approved eye drop for low-lying eyelids, fits into the non-invasive medical…

Friday Sep 22, 2023 - 11:15 am

InvestorNewsBreaks – GEMXX Corp. (GEMZ) Featured in Bell2Bell Podcast

GEMXX (OTC: GEMZ), an enterprise specializing in gold, gemstone and jewelry production, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Richard Clowater, president of GEMXX, joined the program and IBN’s Stuart Smith to provide an introduction of ammolite, an extremely rare gemstone, and discuss the company’s innovative business…

Friday Sep 22, 2023 - 9:46 am

InvestorNewsBreaks — Cepton Inc. (NASDAQ: CPTN) CCO Talks Industrializing Lidar with Automotive Programs, Company’s Reverse Stock Split Takes Effect

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is in the spotlight. Cepton’s new chief commercial officer Mitch Hourtienne was a guest during a recent Proactive Investors interview. During the interview, Hourtienne, who has been serving as Cepton senior vice president, and Proactive Investors host Steve Darling discussed his 20-year-plus journey to Cepton as well as his new responsibilities. Hourtienne has…

Thursday Sep 21, 2023 - 1:55 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces New Studies to Examine DehydraTECH(TM)-Powered GLP-1 Drugs

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its intention to launch new human and animal studies to examine DehydraTECH(TM)-processed glucagon-like peptide-1 (“GLP-1”) drugs such as, but not limited to, semaglutide sold under Novo Nordisk’s brand names Ozempic(R), Wegovy(R) and Rybelsus(R), for purposes of improved bioavailability, cost-effectiveness, tolerability, weight loss potential, management of diabetes and other health conditions. According…

Thursday Sep 21, 2023 - 11:12 am

InvestorNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Cargo Vans Purchased by NYPA on Heels of Successful EV Pilot

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that the New York Power Authority (“NYPA”) has purchased the company’s campus delivery cargo vans after successful completion of an EV pilot program at NYPA’s 16-turbine hydroelectric facility in northern New York. According to the update, the 60-day EV cargo van pilot began on July 6, 2023, and concluded in early September 2023.…

Wednesday Sep 20, 2023 - 12:12 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces 100th Landing of Its Robot Show

Knightscope (NASDAQ: KSCP) is a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems. The company has announced its 100th Robot Roadshow landing that will take place on Oct. 3, 2023, at Rich Township High School in Richton Park, Illinois. The announcement reads, “Knightscope’s Robot Roadshow (‘Roadshow’) was developed and launched during the pandemic, which brought all tradeshows and related gatherings…

Wednesday Sep 20, 2023 - 11:54 am

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Building Protection and Powerful IP Portfolio for Its Diabetes Gene Therapy Program

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, recently announced its entry into an exclusive license agreement related to a particular gene therapy for both type 1 and type 2 diabetes. “Specifically, the announcement involves a worldwide exclusive license to a patent application and related technology, and a worldwide non-exclusive license to use certain…

Tuesday Sep 19, 2023 - 12:19 pm

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Receives IRS Approval as ‘Qualified Manufacturer,’ Qualifies for Federal EV Tax Credit

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has received approval from the IRS for its “qualified manufacturer” designation. The designation means the company qualifies for commercial EV federal tax credits of up to $7,500 per qualified vehicle with gross vehicle weight ratings (“GVWRs”) of under 14,000 pounds. According to the announcement, both the Mullen ONE, a class 1 EV Cargo Van, and the Mullen…

Monday Sep 18, 2023 - 3:36 pm

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Launch of Proprietary Fleet Telematics Solution

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has launched Commercial Pulse, an advanced telematics application for customers that offers a complete solution for vehicle diagnostics and fleet optimization. According to the announcement, Mullen’s Commercial Pulse is an advanced telematics AI app that provides drivers and fleet companies with maintenance alerts, real-time vehicle location, driver safety, battery state of charge, metrics and more…

Monday Sep 18, 2023 - 12:16 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO to Present on Emerging A.I. in Virtual Tech Conference Series

Knightscope (NASDAQ: KSCP) is a leading developer of autonomous security robots and blue light emergency communication systems. The company has announced that its chairman and CEO, William Santana Li, was invited to present at the conference on Emerging Growth in Artificial Intelligence (“A.I.”), a part of the Virtual Tech Conference Series presented by Maxim Group LLC, on Sept. 26 and 27, 2023, at 8:00 a.m.…

Friday Sep 15, 2023 - 2:50 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) New Subsidiary Maximizing Patented DehydraTECH(TM) in Various Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced the incorporation of a new wholly owned subsidiary under the name Lexaria Nutraceutical Corp. (“LEXX Nutra”). “LEXX Nutra will keep with Lexaria’s overall strategy of maximizing the company’s patented DehydraTECH(TM) technology in various markets. Lexaria has issued an exclusive, perpetual license to LEXX Nutra, allowing the use of DehydraTECH to create…

Friday Sep 15, 2023 - 12:26 pm

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Looks Forward to Acclaim-3 Trial on Heels of Receipt of FDA FTD and ODD Designations

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company recently announced that the United States Food and Drug Administration (“FDA”) had granted Orphan Drug Designation (“ODD”) to its lead drug candidate, REQORSA(R) Immunogene Therapy (quratusugene ozeplasmid), for the treatment of small cell lung cancer (“SCLC”). The receipt of the ODD followed the…

Friday Sep 15, 2023 - 12:12 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Optimistic Berubicin May Provide Much-Needed Benefit for GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotechnology company specializing in the development of novel treatments with a focus on brain cancer, glioblastoma (“GBM”) and neuro-oncology, recently presented updated safety results from its potentially pivotal clinical study on GBM treatment through its lead drug candidate, Berubicin. “Most notably, this novel anthracycline demonstrated its capability to be a safe and innovative potential treatment option for GBM, having…

Friday Sep 15, 2023 - 9:48 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Leveraging Technology, Innovative Services to Enhance US Safety

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, is leveraging technology to improve public safety across the U.S. utilizing Amazon.com Inc.’s (NASDAQ: AMZN) Amazon Web Services (“AWS”). The announcement reads, “In Huntington Park, California, Knightscope’s K5 Autonomous Security Robot (‘ASR’) helped reduce calls for service by 10% and crime reports by 46% during its first year of…

Thursday Sep 14, 2023 - 11:00 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Releases Upcoming Destinations for 2023 Strikingly Different EV Experience

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is announcing new stops on its 2023 Strikingly Different EV U.S. tour. This month the EV experience will be in North Carolina as well as Washington, D.C., Philadelphia, New York City and Boston. This year’s Strikingly Different tour began in August, with its first stop in Austin, Texas; the innovative in-person tour is slated to…

Wednesday Sep 13, 2023 - 1:40 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Unveils Grant Program to Ensure School Safety

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, announced the launch of its School Safety Grant Program. According to the announcement, Knightscope’s program makes the safety of schools, children and teachers a top priority and is designed to empower individuals and promote safer learning environments in K-12 schools. Knightscope understands that violence, harassment and threats against…

Tuesday Sep 12, 2023 - 12:00 pm

InvestorNewsBreaks – GEMXX Corp. (GEMZ) Announces Plans to Expand Ammolite Production, On-Air Presence

GEMXX (OTC: GEMZ), a leader in the ammolite gems mine-to-market segment, today announced that demand for GEMXX Ammolite in jewelry designs by Kenneth Bradley is exponentially growing. According to the update, the presence of GEMXX Ammolite is expanding in the United States and around the world. Live, on-air events showcase uniquely beautiful GEMXX Ammolite gemstones in jewelry by Kenneth Bradley designs. In March of 2023,…

Monday Sep 11, 2023 - 12:55 pm

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Strategic Acquisition of Romeo Power Assets

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its purchase of battery pack production assets from Romeo Power for approximately $3.5 million. According to the announcement, the deal includes equipment, inventory and intellectual property for high volume EV battery pack and module production. The assets include production lines for EV pack assembly and precision R&D module and pack development with associated…

Friday Sep 08, 2023 - 12:23 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) ‘Strategically Important’ Patent Grants Protection in One of World’s Leading Oral Nicotine Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently celebrated the receipt of U.S. patent #11,700,875, titled “Compositions and Methods For Sublingual Delivery of Nicotine.” The patent covers various forms and sources of nicotine, including nicotine benzoate, nicotine polacrilex, nicotine citrate, nicotine detartrate, and many others, for use in sublingual delivery formats like oral pouches. “The new U.S. patent is remarkable…

Friday Sep 08, 2023 - 11:26 am

InvestorNewsBreaks – GEMXX Corp. (GEMZ) Eyes Promising Start to Expected ‘Highly Lucrative’ First Year of Gold Mining

GEMXX (OTC: GEMZ), a mine-to-market global jewelry producer, is ramping up its capacity for gold ore processing at one of its Canadian assets, enthusiastic over the better-than-expected amount of ore produced from stockpiled surface material. “GEMXX’s Snow Creek Mine property in British Columbia completed site preparation for gold processing last year and mobilized equipment in May to begin bringing the property into full production. GEMXX…

Friday Sep 08, 2023 - 9:43 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys K5 ASRs for New Client, 2nd-Year Contract Renewal

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced another new deployment and contract renewal for K5 ASRs. The announcement reads, “Knightscope’s commitment to making children safe extends beyond the classroom and into extracurricular and recreational activities. With over 3.5 billion followers worldwide, soccer is the number one sport on planet Earth, and Knightscope has…

Thursday Sep 07, 2023 - 1:29 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 200-Patient Enrollment Milestone in Potentially Pivotal Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced enrollment of 200 of the expected 243 patients in the company’s ongoing potentially pivotal study evaluating Berubicin for the treatment of recurrent Glioblastoma Multiforme (“GBM”), an aggressive and incurable form of brain cancer. “As we have noted…

Thursday Sep 07, 2023 - 1:22 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 25th Annual Global Investment Conference

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing, and commercialization of rare cannabinoids and cannabinoid analogs, today announced its participation in the H.C. Wainwright Global Investment Conference, which is taking place Sept. 11-13, 2023, in New York City. The on-demand presentation by InMed’s CEO Eric A. Adams will be available beginning at 7 a.m. ET on Sept. 11 via webcast, and…

Thursday Sep 07, 2023 - 12:33 pm

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Receives Delisting Notification from NASDAQ, Files an Appeal

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has received a letter from the Listing Qualifications Department of the NASDAQ Stock Market. The letter notes that MULN did not meet the deadline to regain compliance with NASDAQ listing requirements; the deadline was Sept. 5, 2023. According to the notice, the company failed to maintain a minimum bid price of $1. In response to…

Thursday Sep 07, 2023 - 12:28 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 ASRs Deployed to Oregon Hospital and Texas-Based Industrial Facility

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced a new deployment and another contract renewal, which both utilize the company’s K5 ASR. The announcement reads, “An Oregon healthcare organization with more than 70 primary care, specialty and urgent care clinics; a hospital; a children’s hospital; and a 24-hour mental and behavioral health services center,…

Thursday Sep 07, 2023 - 12:02 pm

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Upcoming H.C. Wainwright Conference

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that its CFO Ryan Confer will be providing an overview of the company's pioneering gene therapies for cancer and diabetes at the upcoming H.C. Wainwright 25th Annual Global Investment Conference. Confer’s presentation is scheduled to begin at 3:00 p.m. ET on Wednesday, Sep. 13,…

Wednesday Sep 06, 2023 - 3:03 pm

InvestorNewsBreaks – Why RVL Pharmaceuticals plc (NASDAQ: RVLP) Is ‘One to Watch’

RVL Pharmaceuticals (NASDAQ: RVLP) is a specialty pharmaceutical company focusing on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, available by prescription for the treatment of acquired blepharoptosis (low-lying eyelid(s)) in adults. “UPNEEQ(R) (‘RVL-1201’) is the first non-surgical treatment option approved by the U.S. Food and Drug Administration (‘FDA’) for acquired blepharoptosis. The company received FDA approval in July 2020 and launched UPNEEQ(R) in…

Wednesday Sep 06, 2023 - 10:30 am

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Record Capacity Levels for Fr8Fleet

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform that offers a B2B cloud-based solution for cross-border and domestic shipping within the USMCA region. The company reported a record number of active carriers in its Fr8Fleet brand at end of August 2023, an increase of 60.8% versus year-ago levels and an increase of 55.7% versus YTD average…

Tuesday Sep 05, 2023 - 10:06 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO to Present at Upcoming H.C. Wainwright Conference

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced that it will present virtually at the H.C. Wainwright 25th Annual Global Investment Conference taking place on Monday, Sept. 11, 2023. The announcement reads, “Knightscope’s Chairman and CEO, William Santana Li, will deliver a corporate overview followed by question-and-answer sessions with analysts and attendees. The event begins…

Friday Sep 01, 2023 - 12:24 pm

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures Patent Protection in ‘Some of the Most Important Markets in the World’

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, recently received a patent from the China National Intellectual Property Administration. “The granted patent broadly covers the use of the company’s drug candidate REQORSA(R) immunogene therapy in combination with PD-1 antibodies, such as Keytruda(R), to treat cancers. The REQORSA gene therapy in combination with Keytruda is…

Friday Sep 01, 2023 - 11:43 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 and K1 ASRs to Patrol New York-Based Pharmaceutical Facility

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced a new 7-robot contract with a publicly traded biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. The new client subscribed to one K5 ASR assigned to patrol a 4-story garage and six K1-Tower ASRs to monitor building entrances, open areas…

Friday Sep 01, 2023 - 11:16 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) CEO Responds to Question Asked on ‘Making Money with Charles Payne’

Mullen Automotive’s (NASDAQ: MULN) CEO and Chairman David Michery appeared on “Making Money with Charles Payne” on Fox Business on Thursday, Aug. 31, to discuss the lawsuit against large brokerage firms for unlawful trading practices of the company’s stock and other matters. The company today announced its response to a question asked during Michery’s appearance on the program, which aired on Fox Business at 2:55…

Friday Sep 01, 2023 - 10:35 am

InvestorNewsBreaks — Cepton Inc. (NASDAQ: CPTN) CEO Explains Lidar, Eye Safety During Proactive Investors Interview

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is in the spotlight. Cepton CEO and cofounder Dr. Jun Pei was a guest during a recent Proactive Investors interview. During the interview, Pei and Proactive Investors host Steve Darling discussed the importance of lidar technology and eye safety. Pei specifically talked about lidar impact on human eyes and eye safety, explaining Cepton’s…

Thursday Aug 31, 2023 - 12:06 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Announces Participation for Upcoming Investor Conferences

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced its participation in investor conferences taking place in September 2023. The company’s Chief Financial Officer Hull Xu and Senior VP of Business Development Mitch Hourtienne will present at 8:35 a.m. Pacific Time on Sept. 13 at the RBC Global Industrials Conference in Las Vegas, Nevada. In addition, Xu and Cepton’s…

Wednesday Aug 30, 2023 - 2:51 pm

InvestorNewsBreaks – Why GEMXX Corp. (GEMZ) Is ‘One to Watch’

GEMXX (OTC: GEMZ), a mine-to-market enterprise specializing in gold, gemstone and jewelry production, maintains control over every aspect of its production process, from gold mining and gemstone extraction to jewelry manufacturing and global distribution, with ownership of mineral resources, production facilities and operational assets. “As a prominent player in the industry, GEMXX stands out as a leading producer of high-quality finished ammolite jewelry. Notably, it…

Wednesday Aug 30, 2023 - 12:42 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Update on IND Application Progress

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today provided an update on the status of its anticipated submission of an Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) for the company’s planned U.S. phase 1b hypertension clinical trial designated as HYPER-H23-1. As previously announced, work that was mostly under Lexaria’s control such as batch manufacturing…

InvestorNewsBreaks

NewsBreak Category: Tiny Gems

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions